Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Zydus Lifesciences Limited
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

ZYDUS LIFESCIENCES LIMITED

zyduscadila.com

Active

Updated: 09 Oct 2024

Zydus Lifesciences Limited, is a listed public company incorporated on 15 May, 1995. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 172.50 cr and the total paid-up capital is INR 100.62 cr.

Zydus Lifesciences Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 27.96% over the previous year. At the same time, it's book networth has increased by 3.01%.

Industry

Manufacturing of Pharmaceuticals

Products

injections, syrups., capsules, Tablets

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

28.27%

₹ GET PRO

EBITDA

65.36%

₹ GET PRO

Net Profit

125.05%

₹ GET PRO

Networth

15.23%

₹ GET PRO

Borrowings

30.23%

₹ GET PRO

Assets

17.12%

₹ GET PRO

Gross Margin

7.18

GET PRO %

Operating Margin

9.41

GET PRO %

Net Profit Margin

12.43

GET PRO %

Return on Equity

10.69

GET PRO %

ROCE

13.1

GET PRO %

Debt to Equity

0.04

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (57)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	102.4	102.4	102.4	101.2	100.6
Reserves	11,608.0	14,827.2	18,951.4	19,587.1	22,001.0
Borrowings +	7,041.1	3,680.4	4,196.0	1,163.2	768.6
Long term borrowings	3,214.6	609.5	362.1	-	-
Short term borrowings	3,826.5	3,070.9	3,833.9	1,163.2	768.6
Trade payables +	2,031.0	2,205.9	2,137.8	2,125.0	2,126.7
Days payable	151.0	155.0	141.0	123.0	125.0
Other liabilities +	4,935.1	5,274.7	4,545.6	4,904.9	6,410.6
Other non-current liabilities	492.2	484.3	552.7	541.4	1,839.5
Other current liabilities	2,411.9	2,584.5	1,855.1	2,238.5	2,444.4
Total liabilities	23,686.6	23,884.7	27,795.4	25,756.4	29,280.8
Fixed Assets +	12,972.0	12,916.0	12,914.4	12,721.6	14,791.8
Tangible assets	5,452.2	5,550.0	5,761.6	5,696.5	5,803.3
CWIP	741.5	783.2	661.0	1,200.7	2,423.3
Intangible assets	6,778.3	6,582.8	6,491.8	5,824.4	6,565.2
LT loans and advances	-	-	-	2.0	-
Other non-current assets	1,999.2	2,252.7	2,785.8	3,024.6	3,069.2
Current assets +	8,715.4	8,716.0	12,095.2	10,008.2	11,419.8
Inventories	2,789.0	3,236.2	3,719.4	3,413.3	3,441.9
Trade receivables	3,663.2	3,127.3	3,340.3	4,416.8	5,220.2
Cash and cash equivalents	845.3	665.2	657.8	487.8	413.0
ST loans and advances	-	-	-	0.4	1.5
Other current assets	1,417.9	1,687.3	4,377.7	1,689.9	2,343.2
Total assets	23,686.6	23,884.7	27,795.4	25,756.4	29,280.8

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	0.43	0.43	0.37	0.39	0.34
Reserves	49.01	62.08	68.18	76.05	75.14
Borrowings +	29.73	15.41	15.1	4.52	2.62
Long term borrowings	13.57	2.55	1.3	0.0	0.0
Short term borrowings	16.15	12.86	13.79	4.52	2.62
Trade payables	8.57	9.24	7.69	8.25	7.26
Other liabilities +	20.83	22.08	16.35	19.04	21.89
Other non-current liabilities	2.08	2.03	1.99	2.1	6.28
Other current liabilities	10.18	10.82	6.67	8.69	8.35
Total liabilities
Fixed Assets +	54.77	54.08	46.46	49.39	50.52
Tangible assets	23.02	23.24	20.73	22.12	19.82
CWIP	3.13	3.28	2.38	4.66	8.28
Intangible assets	28.62	27.56	23.36	22.61	22.42
LT loans and advances	0.0	0.0	0.0	0.01	0.0
Other non-current assets	8.44	9.43	10.02	11.74	10.48
Current assets +	36.79	36.49	43.52	38.86	39.0
Inventories	11.77	13.55	13.38	13.25	11.75
Trade receivables	15.47	13.09	12.02	17.15	17.83
Cash and cash equivalents	3.57	2.79	2.37	1.89	1.41
ST loans and advances	0.0	0.0	0.0	0.0	0.01
Other current assets	5.99	7.06	15.75	6.56	8.0
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	14,253.1	15,102.2	15,265.2	17,521.8	19,547.4
Sales growth %	8.26	5.96	1.08	14.78	11.56
Expenses +	12,508.0	12,649.5	12,764.5	14,514.5	15,008.4
Cost of goods	4,920.0	5,210.1	5,545.2	6,310.1	6,228.2
Employee cost	2,414.5	2,490.2	2,434.1	2,765.6	3,137.6
Other costs	4,135.2	4,060.9	3,945.2	4,586.2	4,797.3
Operating profit +	2,783.4	3,341.0	3,340.7	3,859.9	5,384.3
Operating margin %	19.5	22.1	21.9	22.0	27.5
Other income	113.9	37.2	224.7	186.6	284.1
Interest	341.8	163.5	127.0	129.9	81.2
Depreciation	696.5	724.8	713.0	722.7	764.1
Exceptional items	-363.6	-205.1	112.7	-604.2	-14.2
Profit before tax	1,495.4	2,284.8	2,838.1	2,589.7	4,808.9
Tax	319.8	147.2	511.7	587.8	977.5
Profit - disc. ops	-	-	2,245.7	-4.6	23.0
Net profit	1,204.4	2,185.0	4,618.3	2,091.9	3,972.8
Net margin %	8.4	14.4	26.0	11.8	20.0

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	99.21	99.75	98.55	98.95	98.57
Expenses +	87.06	83.55	82.41	81.96	75.68
Cost of goods	34.25	34.41	35.8	35.63	31.41
Employee cost	16.81	16.45	15.71	15.62	15.82
Other costs	28.78	26.82	25.47	25.9	24.19
Operating profit	19.37	22.07	21.57	21.8	27.15
Other income	0.79	0.25	1.45	1.05	1.43
Interest	2.38	1.08	0.82	0.73	0.41
Depreciation	4.85	4.79	4.6	4.08	3.85
Exceptional items	-2.53	-1.35	0.73	-3.41	-0.07
Profit before tax	10.41	15.09	18.32	14.62	24.25
Tax	2.23	0.97	3.3	3.32	4.93
Profit - disc. ops	0.0	0.0	14.5	-0.03	0.12
Net profit	8.38	14.43	29.81	11.81	20.03

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	0.6	0.2	0.2	0.1	0.0
Net Debt/Equity	0.5	0.2	0.2	0.0	0.0
Total Debt/Assets	0.3	0.1	0.1	0.1	0.0
Total Assets/Equity	2.0	1.6	1.5	1.3	1.3
Liquidity +
Current Ratio	1.1	1.1	1.6	1.8	2.1
Quick Ratio	0.7	0.7	1.1	1.2	1.5
Interest Coverage	8.1	20.4	26.3	29.7	66.3
Performance
Gross Margin	65.5	65.5	63.7	64.0	68.1
Operating Margin	19.5	22.1	21.9	22.0	27.5
Net Margin	8.4	14.4	26.0	11.8	20.0
Return +
Return on Equity	10.3	14.6	24.2	10.6	18.0
Pre-tax ROCE	15.6	19.0	15.3	18.2	22.1
Return on Assets	5.1	9.2	16.6	8.1	13.6
Pre-tax ROIC	11.7	14.6	11.6	15.4	20.6
Efficiency +
Days Payable	151.0	155.0	141.0	123.0	125.0
Days Inventory	207.0	227.0	245.0	197.0	202.0
Days Receivable	94.0	76.0	80.0	92.0	97.0
Fixed Asset Turnover	1.1	1.2	1.2	1.4	1.3
Total Asset Turnover	0.6	0.6	0.6	0.7	0.7
Working Capital
Cash Conversion Cycle	150.0	148.0	184.0	166.0	174.0
Working Capital Days	11.0	21.0	102.0	93.0	114.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

ICICI Bank Limited

No. of Loans: 1

Total Amount : 1,500.0 cr

Charge Holder	Amount	Date of creation/modification
ICICI Bank Limited	1,500.0 cr	20 Apr, 2022

Charges

ICICI Bank Limited

People

Designation	Name	DIN/PAN	Tenure
Whole-time Director	Ganesh Narayan Nayak Shareholder	00017481	8 years
Director	Apurva Shishir Diwanji	00032072	9 years
Director	Mukesh Mangalbhai Patel Shareholder	00053892	28 years
Director	Bhadresh Kantilal Shah	00058177	6 years
Director	Pankaj Ramanbhai Patel Shareholder	00131852	30 years
Managing Director	Sharvil Pankajbhai Patel Shareholder	00131995	28 years
CFO	Nitinkumar Dalsukhray Parekh	<HIDDEN>	10 years
Director	Shelina Pranav Parikh	00468199	1 years
Director	Upasana Konidela	02781278	2 years
Director	Monappa Arun Akhil	09784366	2 years
CS	Dhaval Narendra Soni Shareholder	<HIDDEN>	6 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
GERMAN REMEDIES HEALTHCARE PRIVATE LIMITED	Active	1.0 L	1	Maharashtra
ZYDUS ANIMAL HEALTH LIMITED	Amalgamated	24.0 Cr	2	Gujarat
FINEST PROCURING SOLUTIONS LIMITED	Amalgamated	4.0 Cr	1	Delhi
BIOCHEM PHARMACEUTICAL INDUSTRIES LIMITED PART IX	Amalgamated	7.5 Cr	1	Gujarat
ALIDAC PHARMACEUTICALS LIMITED	Amalgamated	99.3 Cr	2	Gujarat
ZYDUS BSV RESEARCH AND DEVELOPMENT PRIVA TE LIMITED	Amalgamated	2.0 Cr	2	Gujarat
ZYDUS TECHNOLOGIES LIMITED	Amalgamated	59.0 Cr	2	Gujarat
ZYDUS VTEC LIMITED	Active	302.5 Cr	1	Gujarat
ZYDUS WELLNESS LIMITED	Active	63.6 Cr	3	Gujarat
ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED	Active	15.0 Cr	1	Gujarat
ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED	Active	20.0 Cr	2	Maharashtra
BOMBAY CHAMBER OF COMMERCE AND INDUSTRY	Active	0.0	1	Maharashtra
BAJAJ ALLIANZ GENERAL INSURANCE COMPANY LIMITED	Active	110.2 Cr	1	Maharashtra
TUV INDIA P LTD	Active	30.0 L	1	Maharashtra
HORMAZE PROPERTY PRIVATE LIMITED	Active	5.0 L	1	Maharashtra
TORRENT POWER LIMITED	Active	480.6 Cr	1	Gujarat
FORCE MOTORS LIMITED	Active	13.2 Cr	1	Maharashtra
SAVANNAH HOTELS PRIVATE LIMITED	Amalgamated	15.8 Cr	1	Maharashtra
GULMOHAR GREENS-GOLF AND COUNTRY CLUB LIMITED	Active	9.8 Cr	1	Gujarat
BAAP DIAGNOSTICS LIMITED	Amalgamated	5.0 L	1	Gujarat
ZYDUS PHARMACEUTICALS LIMITED	Amalgamated	95.0 L	2	Gujarat
DESAI FOODS PRIVATE LIMITED	Active	1.8 Cr	1	Maharashtra
DESAI BROTHERS LTD	Active	2.7 Cr	1	Maharashtra
CLIANTHA RESEARCH LIMITED	Active	3.8 Cr	1	Gujarat
JADE BLUE LIFESTYLE INDIA LIMITED	Active	11.8 Cr	1	Gujarat
WELCAST STEELS LIMITED	Active	63.8 L	1	Gujarat
RECLAMATION WELDING LIMITED	Amalgamated	2.2 Cr	1	Gujarat
CENTRICAST ENTERPRISES PVT LTD	Amalgamated	3.0 L	1	Gujarat
PARAMOUNT CENTRISPUN CASTINGS PRIVATE LI MITED	Amalgamated	1.1 Cr	1	Gujarat
AVIRAT FINANCE PRIVATE LIMITED	Active	3.1 L	1	Gujarat
KEYUR FINANCIAL SERVICES PRIVATE LIMITED	Amalgamated	2.3 Cr	1	Gujarat
AIA CSR FOUNDATION	Active	1.0 L	1	Gujarat
DCPL FOUNDRIES LIMITED	Amalgamated	1.0 Cr	1	Gujarat
ZYDUS HEALTHCARE LIMITED	Active	21.6 Cr	2	Gujarat
AIA ENGINEERING LIMITED	Active	18.7 Cr	1	Gujarat
CADILA LABORATORIES PRIVATE LIMITED	Active	3.8 Cr	2	Gujarat
BAYER CROPSCIENCE LIMITED	Active	44.9 Cr	1	Maharashtra
PRIPAN INVESTMENT PRIVATE LIMITED	Active	286.2 Cr	2	Gujarat
ZYDUS HOSPITALS (VADODRA) PRIVATE LIMITED	Converted to LLP	1.0 L	2	Gujarat
ZYDUS HOSPITALS (RAJKOT) PRIVATE LIMITED	Converted to LLP	1.0 L	2	Gujarat
GRUH FINANCE LIMITED	Amalgamated	146.8 Cr	1	Gujarat
MABS BIOTECH PRIVATE LIMITED	Converted to LLP	5.0 L	1	Gujarat
ZYDUS FOUNDATION	Active	5.0 L	2	Gujarat
ZYDUS HOSPITALS AND MEDICAL RESEARCH PRI VATE LIMITED	Amalgamated	1.0 L	2	Gujarat
WESTERN AHMEDABAD EFFLUENT CONVEYANCE COMPANY PRIVATE LIMITED	Active	1.0 L	2	Gujarat
ZYDUS HEALTHCARE LIMITED	Amalgamated	10.0 Cr	2	Gujarat
CADILA LIFESCIENCES PRIVATE LIMITED	Active	1.0 L	2	Gujarat
ZANDRA HERBS AND PLANTATIONS LLP	Active	1.0 Cr	2	Gujarat
RAJNIGANDHA DEVELOPERS LLP	Active	1.0 L	2	Gujarat
VERTIUS LLP	Active	10.0 L	1	Gujarat
ZANDRA INFRASTRUCTURE LLP	Active	1.0 L	2	Gujarat
ZYDUS HOSPITAL LLP	Active	10.0 L	2	Gujarat
ALETA HOSPITALS LLP	Active	1.0 L	2	Gujarat
ZENILA VENTURES LLP	Active	5.0 L	2	Gujarat
ZYDUS HOSPITALS AND HEALTHCARE RESEARCH PRIVATE LIMITED	Active	1.0 L	2	Gujarat
CADMACH MACHINERY COMPANY PRIVATE LIMITED	Active	22.2 L	2	Gujarat
GREAT EASTERN ENERGY CORPORATION LIMITED	Active	59.6 Cr	1	West Bengal
INVEST INDIA	Active	1.0 Cr	1	Delhi
NIRMA LIMITED	Active	73.0 Cr	1	Gujarat
DIALFORHEALTH INDIA LIMITED	Amalgamated	25.0 Cr	1	Gujarat
LIVA NUTRITIONS LIMITED	Active	3.0 Cr	1	Gujarat
LIVA INVESTMENT LIMITED	Active	25.0 L	1	Gujarat
ZYDUS WELLNESS PRODUCTS LIMITED	Active	218.8 Cr	1	Gujarat
HEINZ INDIA PRIVATE LIMITED	Amalgamated	10.4 Cr	1	Gujarat
TECHNOVA IMAGING SYSTEMS PRIVATE LIMITED	Active	2.0 Cr	1	Maharashtra
TECHNOVA VENTURES PRIVATE LIMITED	Active	42.2 L	1	Maharashtra
TECHNOVA PREPRESS SOLUTIONS PRIVATE LIMITED	Active	1.0 L	1	Maharashtra
TECHNOVA FOUNDATION	Active	1.0 L	1	Maharashtra
KEI VITA PRIVATE LIMITED	Strike Off	1.0 L	1	Telangana
APOLLO HEALTH RESOURCES LIMITED.	Active	3.1 Cr	1	Telangana
TOTAL HEALTH	Active	50.0 L	1	Tamil Nadu
KEI ENERGY PRIVATE LIMITED	Strike Off	1.0 L	1	Telangana
HAPP TECH PRIVATE LIMITED	Active	5.0 Cr	1	Telangana
FHPL TECHNOLOGIES PRIVATE LIMITED	Active	1.0 L	1	Telangana
LIFETIME WELLNESS RX INTERNATIONAL LIMITED	Active	21.1 Cr	1	Telangana
HEALTHNET GLOBAL LIMITED	Active	4.5 Cr	1	Telangana
APOKOS REHAB PRIVATE LIMITED	Active	16.9 Cr	1	Telangana
FAMILY HEALTH PLAN INSURANCE TPA LIMITED	Active	4.0 Cr	1	Telangana
APOLLO TELEHEALTH SERVICES PRIVATE LIMITED	Active	1.0 L	1	Telangana
APOLLO HEALTHCO LIMITED	Active	2,884.9 Cr	1	Tamil Nadu
ZYDUS PHARMACEUTICALS LIMITED	Active	740.0 Cr	1	Gujarat

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Zynext Ventures USA LLC	United States	-	-
Zynext Ventures PTE. LTD	Singapore	-	-
Zydus Pharmaceuticals UK Limited	United Kingdom	-	-
DIALFORHEALTH UNITY LIMITED	Gujarat	2005	₹ 5.0 L
DIALFORHEALTH GREENCROSS LIMITED	Gujarat	2005	₹ 25.0 L
ZYDUS LANKA (PRIVATE) LIMITED	Sri Lanka	-	-
ZYDUS HEALTHCARE PHILIPPINES INC.	Philippines	-	-
ZYDUS INTERNATIONAL PRIVATE LIMITED	Ireland	-	-
ZYDUS NETHERLANDS B.V.	Netherlands	-	-
ZYDUS FRANCE, SAS	France	-	-
LABORATORIOS COMBIX S.L.	Spain	-	-
ETNA BIOTECH S.R.L.	Italy	-	-
ZYDUS PHARMACEUTICALS (USA) INC.	United States	-	-
ZYDUS HEALTHCARE (USA) LLC	United States	-	-
LM MANUFACTURING INDIA PRIVATE LIMITED	Gujarat	2017	₹ 5.0 L
ZYDUS WORLDWIDE DMCC	United Arab Emirates	-	-
ZYDUS HEALTHCARE S.A. (PTY) LTD	South Africa	-	-
Alidac Pharmaceuticals SA Pty Ltd	South Africa	-	-
SCRIPT MANAGEMENT SERVICES (PTY) LTD	South Africa	-	-
ZYDUS NIKKHO FARMACEUTICA LTDA.	Brazil	-	-
Alidac Healthcare (Myanmar) Limited	Myanmar	-	-
Zydus Pharmaceuticals Mexico SA De CV	Mexico	-	-
ZYDUS PHARMACEUTICALS MEXICO SERVICES COMPANY SA DE C.V.	Mexico	-	-
Sentynl Therapeutics Inc.	United States	-	-
GERMAN REMEDIES PHARMACEUTICALS PRIVATE LIMITED	Gujarat	2010	₹ 66.8 Cr
VIOLIO HEALTHCARE LIMITED	Gujarat	2018	₹ 5.0 L
ZYDUS WELLNESS PRODUCTS LIMITED	Gujarat	2019	₹ 218.8 Cr
LIVA INVESTMENT LIMITED	Gujarat	2018	₹ 25.0 L
LIVA NUTRITIONS LIMITED	Gujarat	2018	₹ 3.0 Cr
ZYDUS ANIMAL HEALTH AND INVESTMENTS LIMITED	Gujarat	2018	₹ 1,774.4 Cr
Viona Pharmaceuticals (USA) Inc.	United States	-	-
ZYDUS PHARMACEUTICALS LIMITED	Gujarat	2019	₹ 740.0 Cr
BIOCHEM PHARMACEUTICAL PRIVATE LIMITED	Gujarat	2017	₹ 1.0 L
Zydus Wellness International DMCC	United Arab Emirates	-	-
ZYDUS VTEC LIMITED	Gujarat	2020	₹ 302.5 Cr
ZYDUS STRATEGIC INVESTMENTS LIMITED	Gujarat	2020	₹ 1.0 Cr
Zydus Therapeutics Inc. (USA)	United States	-	-
Zydus Wellness BD Pvt Ltd (Bangladesh)	Bangladesh	-	-
ZYDUS HEALTHCARE LIMITED	Gujarat	1989	₹ 21.6 Cr
ZYDUS WELLNESS LIMITED	Gujarat	1994	₹ 63.6 Cr
LM Manufacturing Limited	United Kingdom	-	-
Medsolutions (Europe) Limited	United Kingdom	-	-
LiqMeds Worldwide Limited	United Kingdom	-	-
LiqMeds Limited	United Kingdom	-	-
LiqMeds Lifecare Limited	United Kingdom	-	-
Zydus Pharmaceuticals (Canda) Inc	Canada	-	-
Zydus Lifesciences Global FZE	United Arab Emirates	-	-
Nesher Pharmaceuticals (USA) LLC	United States	-	-
ZyVet Animal Health Inc.	United States	-	-
Zydus Noveltech Inc.	United States	-	-
Hercon Pharmaceuticals, LLC	United States	-	-

Registered Details

CIN

L24230GJ1995PLC025878

PAN

AAACC6253G

Incorporation

1995, 30.0 years

Company Email

dhavalsoni@zyduslife.com

Paid up Capital

₹ 100.6 Cr

Authorised Capital

₹ 172.5 Cr

AGM

Aug 2024

Type

Public

Non-government Company

FAQ - ZYDUS LIFESCIENCES LIMITED

What is the incorporation date of ZYDUS LIFESCIENCES LIMITED?

The incorporation date of ZYDUS LIFESCIENCES LIMITED is 15 May, 1995

What is the authorized share capital of ZYDUS LIFESCIENCES LIMITED?

The authorized share capital of ZYDUS LIFESCIENCES LIMITED is INR ₹ 172.5 Cr.

What is the paid-up capital of ZYDUS LIFESCIENCES LIMITED?

The paid-up capital of ZYDUS LIFESCIENCES LIMITED is INR ₹ 100.6 Cr.

What is the registered address of ZYDUS LIFESCIENCES LIMITED?

The registered address of ZYDUS LIFESCIENCES LIMITED is Zydus Corporate Park,Scheme No. 63, Survey No. 536 Khoraj( Gandhinagar),Nr. Vaishnodevi Circ le, NA Ahmedabad Ahmedabad Gujarat - 382481

What is the CIN number of ZYDUS LIFESCIENCES LIMITED?

The CIN number of ZYDUS LIFESCIENCES LIMITED is L24230GJ1995PLC025878.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

ZYDUS LIFESCIENCES LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network